First Coronary Artery Study in LifeTec Group's Vascular Bioreactor
A new milestone for LifeTec Group’s vascular bioreactor platform has recently been achieved: a pilot study using porcine coronary arteries has been successfully performed!
-
Preclinical Contract ResearchFocus is on the meaning of the study results, at the same time paving the way for better preclinical processes. -
Tech & TrainingEnable ways of Researching, Developing and Training that weren't deemed possible before. -
Acceleration of medtech innovationHelp medtech innovators turn good ideas into great medical solutions. -
ConsultancyFaster lead times, and thus lower costs, as well as broad, well-documented insights.
-
Preclinical CRO news
First Coronary Artery Study in LifeTec Group's Vascular Bioreactor
A new milestone for LifeTec Group’s vascular bioreactor platform has recently been achieved: a pilot study using porcine coronary arteries has been successfully performed!
-
Lifetec newsLooking Back: First Semester
We’re almost at the end of the first semester of 2019, and at the beginning of the astronomical summer. Here’s our Looking Back @ First Semester:
-
Preclinical CRO newsAngioSupport, designed to offer cardiologists better insights
Tim van den Boom and Bettine van Willigen are currently doing a two-year PDEng doctorate degree for Qualified Medical Engineer. They’re working on an interactive tool called AngioSupport, designed to offer cardiologists better insights into the impact of their decisions when treating coronary artery occlusions. -->>
